Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PARP inhibitors in cancer therapy: Two modes of attack on the cancer cell widening the clinical applications

27 Nov 2009

Abstract excerpt

No abstract is available from the source.

Topics

Join the communities discussing this publication.

DNA Repair Mechanisms
PARP inhibition in cancer therapy
Plant Genetic and Mutation Studies

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 19939726
DOI: 10.1016/j.drup.2009.10.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PARP inhibitors in cancer therapy: Two modes of attack on the cancer cell widening the clinical applicationsPMID 19939726Read ↗

PARP Inhibition in Cancer: An Update on Clinical DevelopmentSemantic proximity Read ↗

Understanding and overcoming resistance to PARP inhibitors in cancer therapySemantic proximity Read ↗

PARP inhibitors: the story is still unfolding.Semantic proximity Read ↗

PARP inhibitors in cancer therapy: an updateSemantic proximity Read ↗

PARP inhibitors coming of ageSemantic proximity Read ↗

PARP inhibitors: New partners in the therapy of cancer and inflammatory diseasesSemantic proximity Read ↗

New PARP targets for cancer therapySemantic proximity Read ↗

PARP Inhibitors in Gynecologic Cancers: What Is the Next Big Development?Semantic proximity Read ↗

Recent development in the discovery of PARP inhibitors as anticancer agents: a patent update (2016-2020)Semantic proximity Read ↗

PARP inhibitors: pitfalls and promises.Semantic proximity Read ↗

Delving into PARP inhibition from bench to bedside and backSemantic proximity Read ↗

PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor ResistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.